LENZ — Lenz Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $441.49m
- $228.21m
- 35
- 20
- 89
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.006 | 19.8 | 377 | 268 | 184 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.006 | 21.1 | 382 | 275 | 188 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 1.46 | 18.1 | 28.2 | 0.321 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.006 | 22.6 | 402 | 322 | 188 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.22 | 32 | 12.1 | 13 | 4.8 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.22 | 32.4 | 17.9 | 25.6 | 4.87 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.22 | -9.8 | 384 | 296 | 184 |
Total Liabilities & Shareholders' Equity | 0.006 | 22.6 | 402 | 322 | 188 |
Total Common Shares Outstanding |